Librarian View
LEADER
04125nam a22004695i 4500
001
b1868360
006
m o d
007
cr un|||||||||
008
220723s2022 mau ob 001 0 eng d
020
|a
9781803927381 (e-book)
035
|a
eep9781803927381
040
|a
DLC
|b
eng
|e
rda
|c
DLC
|d
UtOrBLW
042
|a
pcc
043
|a
e------
050
4
|a
KJC2751.M44
|b
C35 2022
079
|a
(OCoLC)1350601505
100
1
|a
Callesen Klinge, Ulla,
|e
author.
245
1
0
|a
Pharmaceutical patents under the spc regulation /
|c
Ulla Callesen Klinge, PhD (Law) (European patent attorney, M. Sc. (chem. eng.)).
264
1
|a
Northampton :
|b
Edward Elgar Publishing,
|c
2022.
300
|a
1 online resource (286 pages).
336
|a
text
|b
txt
|2
rdacontent.
337
|a
computer
|b
c
|2
rdamedia.
338
|a
online resource
|b
cr
|2
rdacarrier.
490
0
|a
Elgar intellectual property law and practice series.
504
|a
Includes bibliographical references and index.
520
|a
"Written by an experienced European Patent Attorney and scholar, this book sets out in detail the framework for protection of pharmaceutical innovation under the SPC Regulation. With a focus on both biotechnological innovation and secondary innovation, and through extensive reference to the case law, Ulla Klinge surveys the court's evolving interpretation of legal and technical eligibility for this extended term of protection. This book provides clear and pragmatic tools to reflect and guide future practice, while offering key explanations and insights as to why and how technological developments challenge the legal SPC framework. Key Features: - Broad, practitioner-oriented approach offers a useful source of reference alongside practical guidance - Analysis of SPC case law in light of developments in pharmaceutical technology, including both legal and technical aspects of the cases - Examination of the lack of clarity in interpretation of the legislation and how this might be exploited by stakeholders Pharmaceutical Patents under the SPC Regulation is an indispensable practical resource for patent law practitioners, including patent attorneys and attorneys-at-law in the SPC field. It will also prove useful to national patent authorities, legislators, and academics working at the intersection between pharmaceuticals and legal research"--
|c
Provided by publisher.
588
|a
Description based on print record.
505
0
|a
Contents: Preface -- Part I: Introduction and context -- 1. Introduction to pharmaceutical patents under the spc regulation -- 2. The pharmaceutical industry and the surrounding legal and economic environment -- Part II: Legal analysis of the spc regulation as it is -- 3. Background and purpose of the spc system -- 4. Definition of "product" and "medicinal product" -- 5. Eligibility for protection of (medicinal) products under the spc system -- 6. Conditions for obtaining a certificate (art. 3) -- 7. Subject matter of protection (art. 4) and effects of the certificate (art. 5) -- 8. Conclusion on the law as it is -- Part III: Legal analysis of the spc regulation with regard to modern pharmaceutical innovation -- 9. Spc protection for biotechnological medicinal products -- 10. Secondary innovation -- Part IV: General findings and future proposals -- 11. General findings and future proposals -- Bibliography -- Index.
650
0
|a
Drugs
|z
Europe
|v
Patents.
650
0
|a
Pharmaceutical policy.
655
0
|a
Electronic books.
710
2
|a
Edward Elgar Publishing,
|e
publisher.
776
1
|z
9781803927374 (hardback)
830
0
|a
Elgar intellectual property law and practice.
856
4
0
|3
Online book
|u
https://yale.idm.oclc.org/login?url=https://www.elgaronline.com/view/book/9781803927381/9781803927381.xml
907
|a
2023-03-15T00:00:00:000Z
987
|a
Blacklight export from law
953
4
0
|u
https://www.elgaronline.com/view/book/9781803927381/9781803927381.xml
950
|l
inter
902
|a
Yale Internet Resource
|a
Lillian Goldman Law Library
|b
Yale Internet Resource |DELIM|b18683605
901
|a
KJC2751.M44 C35 2022
905
|a
online resource